Skip to main content
. 2024 May 20;30(5):1276–1283. doi: 10.1038/s41591-024-02940-9

Extended Data Fig. 6. Effect of ARCEX Therapy on additional secondary outcomes.

Extended Data Fig. 6

Improvements in secondary outcome domains during the rehabilitation alone period, and during the ARCEX Therapy period. Lower values of PGIC, CGIC and PHQ-9 represent improved quality of life. These results suggest that a longer period of ARCEX Therapy may promote additional benefits. Red color indicates the period of ARCEX Therapy. Statistics represent one-way repeated measures ANOVA with Tukey HSD post-hoc testing. * = p < 0.05. ** = p < 0.01. *** = p < 0.001. Line graphs represent the mean and standard error of the mean for each outcome measure. Statistics provided in Supplementary Data 3.